BDTCOIN ( BDTC ) Is Listed On AscendEX! Trade Now!
FERNANDINA BEACH, Fla., April 27, 2025 ( GLOBE NEWSWIRE ) -- BDTCOIN, the world's first gold-backed cryptocurrency, is now expanding its reach through listing on AscendEX. AscendEX is one of the fastest-growing centralised crypto trading exchanges over 90 M+ Active users and 200 M+ Daily trading ...
Chipotle Turns Cautious on Consumer Sentiment. Is the Stock Still a Long-term Buy?
After warning during its fourth-quarter conference call that 2025 was off to a tough start in January, fast-casual restaurant chain Chipotle Mexican Grill ( NYSE: CMG ) found that traffic never really recovered. it reported its first same-store sales decline since 2020, early in the COVID-19 ...
This is the secret sauce to stock-picking - and what went wrong in my sale of Alphabet
In his Sunday column for Investing Club subscribers, Jim Cramer explores his stock-picking strategy and the difficulties of owning Alphabet's stock.
MRVI IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action - MRVI - Maravai LifeSciences ( NASDAQ:MRVI )
NEW YORK, April 27, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Maravai Lifesciences Holdings, Inc. MRVI between August 7, 2024 and February 24, 2025, both dates inclusive ( the "Class Period" ) , of the important May ...
This S&P 500 Stock Is Down 68%: Should You Buy It Now and Hold for 20 Years?
Because of how well it represents the performance of the overall stock market, investors seem to always have their eyes on the S&P 500 index. This benchmark contains some of the largest and most profitable companies in the U.S.
Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research ( AACR ) Annual Meeting
NEW YORK, April 27, 2025 ( GLOBE NEWSWIRE ) -- Y-mAbs Therapeutics, Inc. ( the "Company" or "Y-mAbs" ) ( Nasdaq: YMAB ) , a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the ...
Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research ( AACR ) Annual Meeting - Y-mAbs Therapeutics ( NASDAQ:YMAB )
NEW YORK, April 27, 2025 ( GLOBE NEWSWIRE ) -- Y-mAbs Therapeutics, Inc. ( the "Company" or "Y-mAbs" ) YMAB, a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of ...
'Three Or Four Times Better': AI 'Godfather' Geoffrey Hinton Says AI Tutors Could Soon Outperform Humans And Make Degrees Obsolete
Artificial intelligence could soon do more than help with homework-it might replace traditional universities altogether. Geoffrey Hinton, known as the "Godfather Of AI," made that prediction during an interview on "The Agenda" with Steve Paikin, a TVO Today program.
Analyst Weighs In: Bitcoin Soared Nearly 11% Last Week, But Where's the Next Resistance Coming? Analyst Weighs In: Bitcoin Soared Nearly 11% Last Week, But Where's the Next Resistance Coming?
An influential cryptocurrency analyst flagged Bitcoin's BTC/USD next resistance level and a potential bearish signal amid the apex cryptocurrency's resurgence this week.
Banned By Columbia, Backed By Millions: 21-Year-Old's AI Startup Cluely Lets You Cheat On Exams, Interviews, And Sales Calls
Cluely, a provocative AI startup born from academic controversy, just closed a $5.3 million seed round led by Abstract Ventures and Susa Ventures.
